ATLASADC Therapeutics SA (ADCT) earnings date: Nov 9, 2026
ADC Therapeutics SA (ADCT) reports earnings for the quarter ended Sep 30, 2026 on Mon, Nov 9, 2026. Analysts expect EPS of -$0.21.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on ADCT
| Last price | $1.53 (+2.7%) |
|---|---|
| Normal 1-day range (±1σ) | ±6.0% |
| Earnings beat history | Beat the EPS estimate in 4 of the last 5 reports |
These figures come from the same calibrated model and valuation as the ADC Therapeutics SA stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
ADC Therapeutics SA reports on Nov 9, 2026. One email the day before, with ATLAS’s read on ADC Therapeutics SA. You can switch it off at any time.
Alert me before ADCT reportsFree to start. Creating an account takes under a minute.
ADCT earnings at a glance
| Next report (confirmed) | Mon, Nov 9, 2026 |
|---|---|
| Time | Not stated |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | -$0.21 |
| Last report | Aug 28, 2026 · Beat |
| Beat rate (last 5 reports) | 4 of 5 (80%) |
| Average EPS surprise | +29.1% |
| Average move around a report | ±8.7% (last 5) |
| Sector | Healthcare · Drug Manufacturers - Specialty & Generic |
ADC Therapeutics SA earnings history: last 5 reports
ADC Therapeutics SA last reported on Aug 28, 2026: EPS of $2.54 against an estimate of $2.30 (+10.4% surprise), a beat.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Aug 28, 2026 | $2.30 | $2.54 | +10.4% | Beat | +4.5% |
| Aug 13, 2026 | -$0.22 | -$0.11 | +50.0% | Beat | -17.9% |
| May 4, 2026 | -$0.20 | -$0.21 | -5.0% | Miss | -1.8% |
| Apr 18, 2026 | $0.39 | $0.41 | +5.1% | Beat | -4.0% |
| Mar 10, 2026 | -$0.27 | -$0.04 | +85.2% | Beat | +15.4% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for ADCT
See the fair value, the probability range and the earnings history of ADC Therapeutics SA on its ATLAS page.
ADC Therapeutics SA (ADCT) stock analysisPlans from €3.99 a month.
ADC Therapeutics SA earnings: frequently asked questions
When does ADC Therapeutics SA (ADCT) report earnings?
ADC Therapeutics SA is scheduled to report on Monday, November 9, 2026 (the time of day has not been stated). ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for ADCT?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is -$0.21 per share (USD). Estimates can change before the report.
How often does ADCT beat earnings estimates?
Of its last 5 reports with a recorded result, ADC Therapeutics SA beat the EPS estimate 4 times; the average surprise was +29.1%. Past results do not predict the next one.
How much does ADCT move around earnings?
Over its last 5 reports the stock moved an average of 8.7% (absolute, from the close before the report day to the close after it), and finished higher 2 of 5 times.
Did ADC Therapeutics SA beat earnings estimates last quarter?
ADC Therapeutics SA last reported on Aug 28, 2026: EPS of $2.54 against an estimate of $2.30 (+10.4% surprise), a beat.
How much does ADCT usually move in a day?
On a normal trading day the ATLAS model puts ADCT’s one-day range at about ±6.0%, with a 49% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Mon, Nov 9, 2026
Educational information, not investment advice. Disclaimer